Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission

Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission

Human immunodeficiency virus (HIV) levels in cervicovaginal lavage (CVL) and plasma samples were evaluated in relation to perinatal transmission in a randomized placebo-controlled trial of brief antenatal zidovudine treatment. Samples were collected at 38 weeks' gestation from 310 women and mor...

Full description

Saved in:
Bibliographic Details
Main Authors: Rutt Chuachoowong, Nathan Shaffer, Wimol Siriwasin, Pongsakdi Chaisilwattana, Nancy L. Young, Philip A. Mock, Sanay Chearskul, Naris Waranawat, Thongpoon Chaowanachan, John Karon, R. J. Simonds, Timothy D. Mastro
Other Authors: Mahidol University
Format: Article
Published: 2018
Subjects:
Medicine
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/26292
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University

Internet

https://repository.li.mahidol.ac.th/handle/123456789/26292

Similar Items